25 XP   0   0   10

Brii Biosciences Ltd
Buy, Hold or Sell?

Let's analyse Brii Biosciences Ltd together

PenkeI guess you are interested in Brii Biosciences Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Brii Biosciences Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Brii Biosciences Ltd

I send you an email if I find something interesting about Brii Biosciences Ltd.

Quick analysis of Brii Biosciences Ltd (30 sec.)










What can you expect buying and holding a share of Brii Biosciences Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
HK$4.74
Expected worth in 1 year
HK$4.05
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
HK$-0.69
Return On Investment
-70.6%

For what price can you sell your share?

Current Price per Share
HK$0.98
Expected price per share
HK$0.88 - HK$1.6
How sure are you?
50%

1. Valuation of Brii Biosciences Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$0.98

Intrinsic Value Per Share

HK$-16.93 - HK$-20.16

Total Value Per Share

HK$-12.19 - HK$-15.43

2. Growth of Brii Biosciences Ltd (5 min.)




Is Brii Biosciences Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$440.7m$456.8m-$16m-3.7%

How much money is Brii Biosciences Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$66.8m-$574.5m$507.6m759.7%
Net Profit Margin-938.1%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Brii Biosciences Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#126 / 1010

Most Revenue
#325 / 1010

Most Profit
#927 / 1010

Most Efficient
#797 / 1010

What can you expect buying and holding a share of Brii Biosciences Ltd? (5 min.)

Welcome investor! Brii Biosciences Ltd's management wants to use your money to grow the business. In return you get a share of Brii Biosciences Ltd.

What can you expect buying and holding a share of Brii Biosciences Ltd?

First you should know what it really means to hold a share of Brii Biosciences Ltd. And how you can make/lose money.

Speculation

The Price per Share of Brii Biosciences Ltd is HK$0.98. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Brii Biosciences Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Brii Biosciences Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$4.74. Based on the TTM, the Book Value Change Per Share is HK$-0.17 per quarter. Based on the YOY, the Book Value Change Per Share is HK$7.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Brii Biosciences Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.09-9.4%-0.09-9.4%-0.79-80.4%-0.30-30.7%-0.30-30.7%
Usd Book Value Change Per Share-0.02-2.3%-0.02-2.3%0.9697.6%0.1515.4%0.1515.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-2.3%-0.02-2.3%0.9697.6%0.1515.4%0.1515.4%
Usd Price Per Share0.94-0.94-4.22-1.29-1.29-
Price to Earnings Ratio-10.26--10.26--5.35--3.90--3.90-
Price-to-Total Gains Ratio-42.59--42.59-4.41--19.09--19.09-
Price to Book Ratio1.55-1.55-6.73-2.07-2.07-
Price-to-Total Gains Ratio-42.59--42.59-4.41--19.09--19.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.125048
Number of shares7996
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.15
Usd Total Gains Per Share-0.020.15
Gains per Quarter (7996 shares)-176.561,208.94
Gains per Year (7996 shares)-706.254,835.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-706-716048364826
20-1413-1422096719662
30-2119-212801450714498
40-2825-283401934319334
50-3531-354002417924170
60-4238-424602901429006
70-4944-495203385033842
80-5650-565803868638678
90-6356-636404352243514
100-7063-707004835748350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.00.00.0%0.04.00.00.0%0.04.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.04.00.0%0.00.04.00.0%0.00.04.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%

Fundamentals of Brii Biosciences Ltd

About Brii Biosciences Ltd

Brii Biosciences Limited engages in the research and development of therapies for the treatment of infectious and central nervous system diseases primarily in China and the United States. The company develops BRII-179, BRII-835, and BRII-877, which are in Phase 2 the development of a functional cure for HBV for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 2; and BRII-732 that is in Phase 1 clinical trail and BRII-753, which is in preclinical stage for the treatment of HIV. It also develops BRII-296 for the treatment of PPD/MDD, anxiety, and other depressive disorders; BRII-297 for treatment of various depressive disorders; BRII-636, BRII-672, and BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative infections; and BRII-658 for oral treatment for patients with chronic NTM lung disease. The company was incorporated in 2017 and is headquartered in Beijing, China.

Fundamental data was last updated by Penke on 2024-04-16 09:21:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Brii Biosciences Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Brii Biosciences Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Brii Biosciences Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -938.1% means that $-9.38 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Brii Biosciences Ltd:

  • The MRQ is -938.1%. The company is making a huge loss. -2
  • The TTM is -938.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-938.1%TTM-938.1%0.0%
TTM-938.1%YOY--938.1%
TTM-938.1%5Y-234.5%-703.6%
5Y-234.5%10Y-234.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-938.1%-200.1%-738.0%
TTM-938.1%-216.8%-721.3%
YOY--288.3%+288.3%
5Y-234.5%-449.1%+214.6%
10Y-234.5%-605.5%+371.0%
1.1.2. Return on Assets

Shows how efficient Brii Biosciences Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Brii Biosciences Ltd to the Biotechnology industry mean.
  • -14.3% Return on Assets means that Brii Biosciences Ltd generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Brii Biosciences Ltd:

  • The MRQ is -14.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.3%TTM-14.3%0.0%
TTM-14.3%YOY-115.3%+101.0%
TTM-14.3%5Y-68.4%+54.1%
5Y-68.4%10Y-68.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.3%-13.3%-1.0%
TTM-14.3%-12.8%-1.5%
YOY-115.3%-11.7%-103.6%
5Y-68.4%-13.9%-54.5%
10Y-68.4%-15.7%-52.7%
1.1.3. Return on Equity

Shows how efficient Brii Biosciences Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Brii Biosciences Ltd to the Biotechnology industry mean.
  • -15.2% Return on Equity means Brii Biosciences Ltd generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Brii Biosciences Ltd:

  • The MRQ is -15.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.2%TTM-15.2%0.0%
TTM-15.2%YOY-124.6%+109.4%
TTM-15.2%5Y-34.9%+19.8%
5Y-34.9%10Y-34.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.2%-16.9%+1.7%
TTM-15.2%-16.1%+0.9%
YOY-124.6%-15.1%-109.5%
5Y-34.9%-19.3%-15.6%
10Y-34.9%-20.2%-14.7%

1.2. Operating Efficiency of Brii Biosciences Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Brii Biosciences Ltd is operating .

  • Measures how much profit Brii Biosciences Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Brii Biosciences Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Brii Biosciences Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y--632.4%+632.4%
1.2.2. Operating Ratio

Measures how efficient Brii Biosciences Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 10.96 means that the operating costs are $10.96 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Brii Biosciences Ltd:

  • The MRQ is 10.960. The company is inefficient in keeping operating costs low. -1
  • The TTM is 10.960. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ10.960TTM10.9600.000
TTM10.960YOY-+10.960
TTM10.9605Y2.740+8.220
5Y2.74010Y2.7400.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.9603.231+7.729
TTM10.9603.310+7.650
YOY-3.890-3.890
5Y2.7405.739-2.999
10Y2.7407.876-5.136

1.3. Liquidity of Brii Biosciences Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Brii Biosciences Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 13.43 means the company has $13.43 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Brii Biosciences Ltd:

  • The MRQ is 13.430. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.430. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ13.430TTM13.4300.000
TTM13.430YOY12.162+1.268
TTM13.4305Y10.450+2.980
5Y10.45010Y10.4500.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.4303.890+9.540
TTM13.4304.173+9.257
YOY12.1625.344+6.818
5Y10.4506.126+4.324
10Y10.4506.448+4.002
1.3.2. Quick Ratio

Measures if Brii Biosciences Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Brii Biosciences Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 20.97 means the company can pay off $20.97 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Brii Biosciences Ltd:

  • The MRQ is 20.969. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 20.969. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ20.969TTM20.9690.000
TTM20.969YOY13.914+7.054
TTM20.9695Y12.767+8.202
5Y12.76710Y12.7670.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.9693.514+17.455
TTM20.9693.998+16.971
YOY13.9145.380+8.534
5Y12.7676.105+6.662
10Y12.7676.404+6.363

1.4. Solvency of Brii Biosciences Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Brii Biosciences Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Brii Biosciences Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.06 means that Brii Biosciences Ltd assets are financed with 5.8% credit (debt) and the remaining percentage (100% - 5.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Brii Biosciences Ltd:

  • The MRQ is 0.058. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.058. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.058TTM0.0580.000
TTM0.058YOY0.083-0.025
TTM0.0585Y1.026-0.968
5Y1.02610Y1.0260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0580.339-0.281
TTM0.0580.336-0.278
YOY0.0830.271-0.188
5Y1.0260.366+0.660
10Y1.0260.389+0.637
1.4.2. Debt to Equity Ratio

Measures if Brii Biosciences Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Brii Biosciences Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 6.2% means that company has $0.06 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Brii Biosciences Ltd:

  • The MRQ is 0.062. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.062. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.0620.000
TTM0.062YOY0.090-0.028
TTM0.0625Y0.038+0.024
5Y0.03810Y0.0380.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0620.388-0.326
TTM0.0620.402-0.340
YOY0.0900.335-0.245
5Y0.0380.426-0.388
10Y0.0380.461-0.423

2. Market Valuation of Brii Biosciences Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Brii Biosciences Ltd generates.

  • Above 15 is considered overpriced but always compare Brii Biosciences Ltd to the Biotechnology industry mean.
  • A PE ratio of -10.26 means the investor is paying $-10.26 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Brii Biosciences Ltd:

  • The EOD is -1.364. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.257. Based on the earnings, the company is expensive. -2
  • The TTM is -10.257. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.364MRQ-10.257+8.893
MRQ-10.257TTM-10.2570.000
TTM-10.257YOY-5.350-4.907
TTM-10.2575Y-3.902-6.355
5Y-3.90210Y-3.9020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.364-2.264+0.900
MRQ-10.257-2.629-7.628
TTM-10.257-2.680-7.577
YOY-5.350-4.145-1.205
5Y-3.902-6.257+2.355
10Y-3.902-6.254+2.352
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Brii Biosciences Ltd:

  • The EOD is -1.039. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.816. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.816. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.039MRQ-7.816+6.777
MRQ-7.816TTM-7.8160.000
TTM-7.816YOY-25.300+17.484
TTM-7.8165Y-8.279+0.463
5Y-8.27910Y-8.2790.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.039-2.973+1.934
MRQ-7.816-3.333-4.483
TTM-7.816-3.553-4.263
YOY-25.300-5.605-19.695
5Y-8.279-8.376+0.097
10Y-8.279-8.865+0.586
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Brii Biosciences Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.55 means the investor is paying $1.55 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Brii Biosciences Ltd:

  • The EOD is 0.207. Based on the equity, the company is cheap. +2
  • The MRQ is 1.555. Based on the equity, the company is underpriced. +1
  • The TTM is 1.555. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.207MRQ1.555-1.348
MRQ1.555TTM1.5550.000
TTM1.555YOY6.728-5.173
TTM1.5555Y2.071-0.516
5Y2.07110Y2.0710.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.2071.896-1.689
MRQ1.5552.115-0.560
TTM1.5552.093-0.538
YOY6.7282.884+3.844
5Y2.0713.542-1.471
10Y2.0713.916-1.845
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Brii Biosciences Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.173-0.1730%7.498-102%1.185-115%1.185-115%
Book Value Per Share--4.7404.7400%4.913-4%1.539+208%1.539+208%
Current Ratio--13.43013.4300%12.162+10%10.450+29%10.450+29%
Debt To Asset Ratio--0.0580.0580%0.083-30%1.026-94%1.026-94%
Debt To Equity Ratio--0.0620.0620%0.090-31%0.038+63%0.038+63%
Dividend Per Share----0%-0%-0%-0%
Eps---0.719-0.7190%-6.178+760%-2.359+228%-2.359+228%
Free Cash Flow Per Share---0.943-0.9430%-1.306+39%-0.746-21%-0.746-21%
Free Cash Flow To Equity Per Share---0.947-0.9470%3.486-127%0.887-207%0.887-207%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---20.165--------
Intrinsic Value_10Y_min---16.934--------
Intrinsic Value_1Y_max---1.183--------
Intrinsic Value_1Y_min---1.150--------
Intrinsic Value_3Y_max---4.193--------
Intrinsic Value_3Y_min---3.948--------
Intrinsic Value_5Y_max---7.972--------
Intrinsic Value_5Y_min---7.268--------
Market Cap714250467.840-652%5371455048.9605371455048.9600%24087732614.400-78%7364796915.840-27%7364796915.840-27%
Net Profit Margin---9.381-9.3810%--100%-2.345-75%-2.345-75%
Operating Margin----0%-0%-0%-0%
Operating Ratio--10.96010.9600%-+100%2.740+300%2.740+300%
Pb Ratio0.207-652%1.5551.5550%6.728-77%2.071-25%2.071-25%
Pe Ratio-1.364+87%-10.257-10.2570%-5.350-48%-3.902-62%-3.902-62%
Price Per Share0.980-652%7.3707.3700%33.050-78%10.105-27%10.105-27%
Price To Free Cash Flow Ratio-1.039+87%-7.816-7.8160%-25.300+224%-8.279+6%-8.279+6%
Price To Total Gains Ratio-5.663+87%-42.588-42.5880%4.408-1066%-19.090-55%-19.090-55%
Quick Ratio--20.96920.9690%13.914+51%12.767+64%12.767+64%
Return On Assets---0.143-0.1430%-1.153+707%-0.684+379%-0.684+379%
Return On Equity---0.152-0.1520%-1.246+722%-0.349+130%-0.349+130%
Total Gains Per Share---0.173-0.1730%7.498-102%1.185-115%1.185-115%
Usd Book Value--440773288.682440773288.6820%456866837.993-4%143161939.342+208%143161939.342+208%
Usd Book Value Change Per Share---0.022-0.0220%0.957-102%0.151-115%0.151-115%
Usd Book Value Per Share--0.6050.6050%0.627-4%0.196+208%0.196+208%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.092-0.0920%-0.788+760%-0.301+228%-0.301+228%
Usd Free Cash Flow---87692196.885-87692196.8850%-121484069.706+39%-69373128.890-21%-69373128.890-21%
Usd Free Cash Flow Per Share---0.120-0.1200%-0.167+39%-0.095-21%-0.095-21%
Usd Free Cash Flow To Equity Per Share---0.121-0.1210%0.445-127%0.113-207%0.113-207%
Usd Market Cap91138359.696-652%685397664.247685397664.2470%3073594681.597-78%939748086.461-27%939748086.461-27%
Usd Price Per Share0.125-652%0.9400.9400%4.217-78%1.289-27%1.289-27%
Usd Profit---66822405.771-66822405.7710%-574502402.264+760%-219336697.608+228%-219336697.608+228%
Usd Revenue--7123039.5297123039.5290%-+100%1780759.882+300%1780759.882+300%
Usd Total Gains Per Share---0.022-0.0220%0.957-102%0.151-115%0.151-115%
 EOD+3 -5MRQTTM+0 -0YOY+16 -165Y+15 -1710Y+15 -17

3.2. Fundamental Score

Let's check the fundamental score of Brii Biosciences Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.364
Price to Book Ratio (EOD)Between0-10.207
Net Profit Margin (MRQ)Greater than0-9.381
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than120.969
Current Ratio (MRQ)Greater than113.430
Debt to Asset Ratio (MRQ)Less than10.058
Debt to Equity Ratio (MRQ)Less than10.062
Return on Equity (MRQ)Greater than0.15-0.152
Return on Assets (MRQ)Greater than0.05-0.143
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Brii Biosciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.626
Ma 20Greater thanMa 500.963
Ma 50Greater thanMa 1001.238
Ma 100Greater thanMa 2001.719
OpenGreater thanClose1.010
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,391,849
Total Liabilities197,235
Total Stockholder Equity3,194,614
 As reported
Total Liabilities 197,235
Total Stockholder Equity+ 3,194,614
Total Assets = 3,391,849

Assets

Total Assets3,391,849
Total Current Assets3,076,899
Long-term Assets314,950
Total Current Assets
Cash And Cash Equivalents 1,190,572
Short-term Investments 1,806,812
Other Current Assets 79,515
Total Current Assets  (as reported)3,076,899
Total Current Assets  (calculated)3,076,899
+/-0
Long-term Assets
Property Plant Equipment 19,522
Intangible Assets 146,887
Other Assets 2,513
Long-term Assets  (as reported)314,950
Long-term Assets  (calculated)168,922
+/- 146,028

Liabilities & Shareholders' Equity

Total Current Liabilities229,113
Long-term Liabilities5,239
Total Stockholder Equity3,194,614
Total Current Liabilities
Total Current Liabilities  (as reported)229,113
Total Current Liabilities  (calculated)0
+/- 229,113
Long-term Liabilities
Long term Debt Total 3,156
Other Liabilities 2,083
Long-term Liabilities  (as reported)5,239
Long-term Liabilities  (calculated)5,239
+/-0
Total Stockholder Equity
Common Stock24
Retained Earnings -6,447,432
Capital Surplus 9,352,113
Total Stockholder Equity (as reported)3,194,614
Total Stockholder Equity (calculated)2,904,705
+/- 289,909
Other
Capital Stock24
Cash And Equivalents1,190,572
Cash and Short Term Investments 2,997,384
Common Stock Shares Outstanding 727,203
Liabilities and Stockholders Equity 3,391,849
Net Invested Capital 3,194,614
Net Tangible Assets 3,047,727
Net Working Capital 2,847,786
Property Plant and Equipment Gross 37,353



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-31
> Total Assets 
1,039,424
1,267,944
3,611,699
3,391,849
3,391,8493,611,6991,267,9441,039,424
   > Total Current Assets 
885,457
1,092,842
3,413,941
3,076,899
3,076,8993,413,9411,092,842885,457
       Cash And Cash Equivalents 
880,359
1,034,965
2,855,093
1,190,572
1,190,5722,855,0931,034,965880,359
       Short-term Investments 
0
20,000
499,647
1,806,812
1,806,812499,64720,0000
       Net Receivables 
2,889
24,796
51,517
0
051,51724,7962,889
       Other Current Assets 
349
10,136
7,684
79,515
79,5157,68410,136349
   > Long-term Assets 
153,967
175,102
197,758
314,950
314,950197,758175,102153,967
       Property Plant Equipment 
56,770
43,919
33,435
19,522
19,52233,43543,91956,770
       Intangible Assets 
0
12,222
9,506
146,887
146,8879,50612,2220
       Other Assets 
2,317
2,414
2,786
2,513
2,5132,7862,4142,317
> Total Liabilities 
1,652,185
3,010,646
300,443
197,235
197,235300,4433,010,6461,652,185
   > Total Current Liabilities 
61,884
575,235
280,713
229,113
229,113280,713575,23561,884
       Other Current Liabilities 
37,066
80,546
65,916
0
065,91680,54637,066
   > Long-term Liabilities 
1,590,301
2,435,411
19,730
5,239
5,23919,7302,435,4111,590,301
       Long term Debt Total 
1,562,386
2,423,328
12,647
3,156
3,15612,6472,423,3281,562,386
       Other Liabilities 
27,915
12,083
7,083
2,083
2,0837,08312,08327,915
> Total Stockholder Equity
-612,761
-1,738,289
3,342,904
3,194,614
3,194,6143,342,904-1,738,289-612,761
   Common Stock
7
7
23
24
242377
   Retained Earnings -6,447,432-6,037,898-1,874,049-684,449
   Capital Surplus 
62,274
74,332
9,317,066
9,352,113
9,352,1139,317,06674,33262,274
   Treasury Stock0000
   Other Stockholders Equity 
9,407
61,421
63,713
3,194,590
3,194,59063,71361,4219,407



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue51,626
Cost of Revenue--
Gross Profit-51,626
 
Operating Income (+$)
Gross Profit-
Operating Expense-565,814
Operating Income-488,930-565,814
 
Operating Expense (+$)
Research Development440,634
Selling General Administrative195,490
Selling And Marketing Expenses-
Operating Expense565,814636,124
 
Net Interest Income (+$)
Interest Income851
Interest Expense-19,478
Other Finance Cost-54,980
Net Interest Income36,353
 
Pretax Income (+$)
Operating Income-488,930
Net Interest Income36,353
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-489,781-488,930
EBIT - interestExpense = -19,478
-484,312
-464,834
Interest Expense19,478
Earnings Before Interest and Taxes (EBIT)--470,303
Earnings Before Interest and Taxes (EBITDA)-471,898
 
After tax Income (+$)
Income Before Tax-489,781
Tax Provision-0
Net Income From Continuing Ops-489,781-489,781
Net Income-484,312
Net Income Applicable To Common Shares-484,312
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--36,353
 

Technical Analysis of Brii Biosciences Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Brii Biosciences Ltd. The general trend of Brii Biosciences Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Brii Biosciences Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Brii Biosciences Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.05 < 1.09 < 1.6.

The bearish price targets are: 0.88.

Tweet this
Brii Biosciences Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Brii Biosciences Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Brii Biosciences Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Brii Biosciences Ltd. The current macd is -0.06015894.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Brii Biosciences Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Brii Biosciences Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Brii Biosciences Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Brii Biosciences Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBrii Biosciences Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Brii Biosciences Ltd. The current adx is 27.22.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Brii Biosciences Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Brii Biosciences Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Brii Biosciences Ltd. The current sar is 0.85.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Brii Biosciences Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Brii Biosciences Ltd. The current rsi is 44.63. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Brii Biosciences Ltd Daily Relative Strength Index (RSI) ChartBrii Biosciences Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Brii Biosciences Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Brii Biosciences Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Brii Biosciences Ltd Daily Stochastic Oscillator ChartBrii Biosciences Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Brii Biosciences Ltd. The current cci is 45.45.

Brii Biosciences Ltd Daily Commodity Channel Index (CCI) ChartBrii Biosciences Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Brii Biosciences Ltd. The current cmo is -1.6681712.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Brii Biosciences Ltd Daily Chande Momentum Oscillator (CMO) ChartBrii Biosciences Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Brii Biosciences Ltd. The current willr is -38.0952381.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Brii Biosciences Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Brii Biosciences Ltd Daily Williams %R ChartBrii Biosciences Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Brii Biosciences Ltd.

Brii Biosciences Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Brii Biosciences Ltd. The current atr is 0.08097241.

Brii Biosciences Ltd Daily Average True Range (ATR) ChartBrii Biosciences Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Brii Biosciences Ltd. The current obv is -138,791,626.

Brii Biosciences Ltd Daily On-Balance Volume (OBV) ChartBrii Biosciences Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Brii Biosciences Ltd. The current mfi is 57.37.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Brii Biosciences Ltd Daily Money Flow Index (MFI) ChartBrii Biosciences Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Brii Biosciences Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Brii Biosciences Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Brii Biosciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.626
Ma 20Greater thanMa 500.963
Ma 50Greater thanMa 1001.238
Ma 100Greater thanMa 2001.719
OpenGreater thanClose1.010
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Brii Biosciences Ltd with someone you think should read this too:
  • Are you bullish or bearish on Brii Biosciences Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Brii Biosciences Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Brii Biosciences Ltd

I send you an email if I find something interesting about Brii Biosciences Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Brii Biosciences Ltd.

Receive notifications about Brii Biosciences Ltd in your mailbox!